Triple
T36600424
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CLEOPATRA trial |
E902898
|
entity |
| Predicate | biomarkerRequirement |
P185926
|
FINISHED |
| Object | HER2 overexpression or amplification |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: HER2 overexpression or amplification | Statement: [CLEOPATRA trial, biomarkerRequirement, HER2 overexpression or amplification]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: biomarkerRequirement Context triple: [CLEOPATRA trial, biomarkerRequirement, HER2 overexpression or amplification]
-
A.
usedAsBiomarkerFor
Indicates that one entity serves as a biomarker for another entity, typically signaling the presence, progression, or risk of a specific condition or biological state.
-
B.
diagnosticBiomarker
Indicates that one entity serves as a measurable biological indicator used to detect, confirm, or help diagnose a condition or disease in another entity.
-
C.
hasTargetDisease
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
-
D.
indicationTestedIn
Indicates that a particular medical indication (disease or condition) has been evaluated or tested in a specified clinical study or experimental context.
-
E.
hasPreclinicalFeature
Indicates that an entity exhibits a characteristic, sign, or attribute that is present before the full clinical manifestation of a condition or disease.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f76e66b7b88190848f7a3e1188915f |
completed | May 3, 2026, 3:48 p.m. |
| NER | Named-entity recognition | batch_69f7c371931c8190afb1d4dd5157f92c |
completed | May 3, 2026, 9:51 p.m. |
| PD | Predicate disambiguation | batch_69f7c1baf25c8190a78dd54a400d2c50 |
completed | May 3, 2026, 9:44 p.m. |
| PDg | Predicate description generation | batch_69f7c3705b5c81908c84004543a71c07 |
completed | May 3, 2026, 9:51 p.m. |
Created at: May 3, 2026, 4:11 p.m.